Sie sind auf Seite 1von 1

PHILIPPINES

Dengue Cases Snapshot (January - June 2019)

The Philippines is facing a surge in dengue cases, with over


100,000 dengue cases reported by the Department of Health 47%
Batanes No. of cases
(DOH) from 1 January to 29 June 2019, an 85 per cent increase in
cases from the same period last year, with more than 450 deaths < 1,000
456
reported. On 15 July, the Department of Health declared a National Dengue
Alert, urging regional DOH offices to step up surveillance, case management
1,001 - 2,000
2,001 - 3,000 106,630 deaths 5-9
most affected
and outbreak response in health facilities and hospitals, as well community 3,001 - 4,000 reported cases 53% age group
and school-based health education campaigns, clean-up drives, and logistics Cagayan > 4,000
support for dengue control. While there are many reasons for the increase in
the Philippines, WHO cites that drought and water shortages related to the
onset of El Niño has led people to collect water in containers and an No. of deaths Regions that exceeded the epidemic threshold
increase in mosquito breeding places. 1-5
6 - 10
Regions which have exceeded the epidemic threshold, which is the critical
11 - 20
number required for an epidemic to occur, are CALABARZON, Bicol Region, National Capital Region
Western Visayas, Zamboanga Peninsula, and Northern Mindanao. Other 21 - 30
affected regions are the Cordillera Administrative Region, Eastern Visayas, > 30
the Bangsamoro Autonomous Region in Muslim Mindanao (BARMM) and
Third
Metro Manila (NCR). The provinces of Iloilo, Capiz, Aklan Antique and District
Region IV-A Region V Region VI Region IX Region X
Guimaras in the Western Visayas region declared an outbreak, with many Second NCR
(CALABARZON) (Bicol (Western (Zamboanga (Northern
municipalities seeking a state of calamity to access emergency funding to MANILA District
Cavite Region) Visayas) Peninsula) Mindanao)
mobilise additional resources. WHO is supporting the DOH with First
District
epidemiological analysis and rapid risk assessments, preparing targeted risk
communication messages for health workers and communities to ensure Fourth
District
early detection. In 2017, the Philippines Food and Drug Administration (FDA)
suspended the license of the dengue vaccine Dengvaxia following a
Government & partners’ major responses/interventions
controversy regarding a pilot vaccination campaign. In 2019, the FDA
announced that it permanently revoked the license to distribute Dengvaxia in
the Philippines.
Tacloban
Iloilo City
Trends of reported dengue cases and deaths in the last five years Conduct of risk
National health
Cases Deaths
Cebu
cluster coordination assessments &
Negros Occidental
analysis (brgy. level)
120,000 500
456
450
100,000 106,630 400
350
80,000 317 Bukidnon Reactivation of Clean-up efforts
334 300
Cotabato North
dengue fastlanes & vector control
69,297 285 Zamboanga Cotabato Davao in health facilities
60,000 57,564 250 Sibugay City
City
50,835
45,338 200
40,000
159 150 South Cotabato

100
20,000
50 Community-level
Strengthen Infomation
0 0 & Education Campaign capacity building
2015 2016 2017 2018 2019
Period from January-June of each year Epidemic threshold level

The boundaries, names shown and the designations used on this map do not imply official endorsement or acceptance by the United Nations.
Creation date: 16 July 2019 Sources: DOH, WHO, PSA Feedback: ochaphilippines@un.org www.unocha.org www.reliefweb.int

Das könnte Ihnen auch gefallen